Cargando…

Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma

Detalles Bibliográficos
Autores principales: Brochez, Lieve, Meireson, Annabel, Chevolet, Inès, Sundahl, Nora, Ost, Piet, Kruse, Vibeke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062523/
https://www.ncbi.nlm.nih.gov/pubmed/30050132
http://dx.doi.org/10.1038/s41467-018-05047-1
_version_ 1783342386122850304
author Brochez, Lieve
Meireson, Annabel
Chevolet, Inès
Sundahl, Nora
Ost, Piet
Kruse, Vibeke
author_facet Brochez, Lieve
Meireson, Annabel
Chevolet, Inès
Sundahl, Nora
Ost, Piet
Kruse, Vibeke
author_sort Brochez, Lieve
collection PubMed
description
format Online
Article
Text
id pubmed-6062523
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60625232018-07-30 Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma Brochez, Lieve Meireson, Annabel Chevolet, Inès Sundahl, Nora Ost, Piet Kruse, Vibeke Nat Commun Correspondence Nature Publishing Group UK 2018-07-26 /pmc/articles/PMC6062523/ /pubmed/30050132 http://dx.doi.org/10.1038/s41467-018-05047-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Brochez, Lieve
Meireson, Annabel
Chevolet, Inès
Sundahl, Nora
Ost, Piet
Kruse, Vibeke
Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
title Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
title_full Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
title_fullStr Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
title_full_unstemmed Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
title_short Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
title_sort challenging pd-l1 expressing cytotoxic t cells as a predictor for response to immunotherapy in melanoma
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062523/
https://www.ncbi.nlm.nih.gov/pubmed/30050132
http://dx.doi.org/10.1038/s41467-018-05047-1
work_keys_str_mv AT brochezlieve challengingpdl1expressingcytotoxictcellsasapredictorforresponsetoimmunotherapyinmelanoma
AT meiresonannabel challengingpdl1expressingcytotoxictcellsasapredictorforresponsetoimmunotherapyinmelanoma
AT chevoletines challengingpdl1expressingcytotoxictcellsasapredictorforresponsetoimmunotherapyinmelanoma
AT sundahlnora challengingpdl1expressingcytotoxictcellsasapredictorforresponsetoimmunotherapyinmelanoma
AT ostpiet challengingpdl1expressingcytotoxictcellsasapredictorforresponsetoimmunotherapyinmelanoma
AT krusevibeke challengingpdl1expressingcytotoxictcellsasapredictorforresponsetoimmunotherapyinmelanoma